Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

DENVER -- Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis ...

Poul Weihrauch is to be a “board observer” at the pharma group, which markets GLP-1 drugs under brands including Ozempic and ...

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond ...

Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." ...

MENU - ORDER AI, the AI-powered dining companion helping users choose high-protein, GLP-1 friendly meals in seconds, announced today that it has become the #1 app searched for GLP-1 meal guidance on ...

GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight Americans now say they are taking the shots, which first became popularized ...

These medications could be one reason why weight room floors seem busier than ever.

Weight loss drug developer Kailera Therapeutics (KLRA) and Alamar Biosciences (ALMR), a commercial-stage proteomics company, ...

Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...